300832 ShenZhen New Industries Biomedical Engineering
- 69.28
- +3.91+5.98%
ShenZhen New Industries Biomedical Engineering News
New industry (300832): Overseas revenue continued to increase in Q3, and mid-range and high-end models accelerated breakthroughs
New industry (300832): Promoting steady growth at home and abroad with medium and large instruments in an orderly manner
New industry (300832): Steady growth is in line with expectations, mid-range and high-end installed capacity continues to rise
New Industries (300832) 2024 Quarterly Report Review: Rapid Overseas Growth, Smooth Promotion of Mainframes and Assembly Lines
New industries (300832): Steady domestic revenue growth, rapid overseas growth
New industry (300832): Continued high growth overseas, continued expansion of high-end machines
New Industries (300832) Third Quarterly Report Review: Steady Growth, Changes in Profit Items Affect Apparent Growth Rate
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.79 Yuan From 95.86 Yuan, Keeps at Buy
New industry (300832): pioneer of domestic chemiluminescence going overseas
Research reports emphasize that shenzhen new industries biomedical engineering will develop with dual drivers both domestically and overseas, initiating coverage with a "buy" rating.
New industry (300832): domestic chemical luminescence pioneer import substitutation+overseas breakthrough consolidates the foundation for growth
New industry (300832): Net profit due to mother increased 21% year-on-year in the second quarter of a single quarter T8 assembly lines helped make inspection intelligent
New industry (300832): Performance is in line with the expected trend and is improving, consolidating high growth throughout the year
New industry (300832): Overseas markets and high-end models continue to drive growth
New industries (300832): Maintaining rapid growth overseas and increasing the share of mainframes
New industry (300832): Performance is in line with expectations, X series instruments and assembly lines performed well
New industry (300832): high-end products increase gross profit and maintain steady growth at home and abroad
New industry (300832): continuous release of reagents to optimize the installed structure
New industry (300832): Continued increase in mainframe share helps steady growth in performance
New industry (300832): Performance is in line with expectations, steady and rapid growth at home and abroad
Analysis
Price Target
No Data
No Data